Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double‐blind, placebo‐controlled, multiple‐ascending‐dose phase I trial
Hannon, Rosemary A, Clack, Glen, Rimmer, Martin, Swaisland, Alan, Lockton, J Andrew, Finkelman, Richard D, Eastell, Richard
Published in Journal of bone and mineral research (01.03.2010)
Published in Journal of bone and mineral research (01.03.2010)
Get full text
Journal Article
Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index
Ruge, Toralph, Lockton, J. Andrew, Renstrom, Frida, Lystig, Theodore, Sukonina, Valentina, Svensson, Maria K, Eriksson, Jan W
Published in Metabolism, clinical and experimental (01.06.2009)
Published in Metabolism, clinical and experimental (01.06.2009)
Get full text
Journal Article
Single dose glucagon (0.5 mg IV bolus) administration in healthy human volunteers is a robust model for assessment of glycogenolysis: characterisation of the glucose excursion after glucagon challenge
Lockton, J Andrew, Poucher, Simon M
Published in Journal of pharmacological and toxicological methods (01.01.2007)
Published in Journal of pharmacological and toxicological methods (01.01.2007)
Get full text
Journal Article
Erratum: Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial
Hannon, Rosemary A, Clack, Glen, Rimmer, Martin, Swaisland, Alan, Lockton, J Andrew, Finkelman, Richard D, Eastell, Richard
Published in Journal of bone and mineral research (01.06.2012)
Published in Journal of bone and mineral research (01.06.2012)
Get full text
Journal Article